World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
79
Citations
23599
World Ranking
1681
National Ranking
829

Rongfu Wang publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Rongfu Wang sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 159 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Rongfu Wang D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Rongfu Wang sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 79 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Rongfu Wang is affiliated with the University of Southern California in the United States and has contributed extensively to the field of Medicine, with a primary focus on Radiology, Nuclear Medicine and Imaging. Their research spans multiple subfields including Oncology, Pulmonary and Respiratory Medicine, Immunology, and Pathology and Forensic Medicine.

The scientist's work explores specialized topics such as Radiomics and Machine Learning in Medical Imaging, Monoclonal and Polyclonal Antibodies Research, Radiopharmaceutical Chemistry and Applications, Medical Imaging Techniques and Applications, Lymphoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, as well as Immunotherapy and Immune Responses.

Rongfu Wang has been published in a variety of academic venues, including Molecular Pharmaceutics and World Chinese Journal of Digestology-each venue holding two publications by Wang-as well as the Journal of Nuclear Medicine, Advanced Science, and Thyroid.

The following are recent papers authored or co-authored by Rongfu Wang:

  • Noninvasive Evaluation of CD20 Expression Using 64Cu-Labeled F(ab')2 Fragments of Obinutuzumab in Lymphoma, 2020, Journal of Nuclear Medicine
  • CD38-Targeted Theranostics of Lymphoma with 89Zr/177Lu-Labeled Daratumumab, 2021, Advanced Science
  • Donafenib in Progressive Locally Advanced or Metastatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Results of a Randomized, Multicenter Phase II Trial, 2020, Thyroid
  • ImmunoPET of CD146 in Orthotopic and Metastatic Breast Cancer Models, 2021, Bioconjugate Chemistry
  • 64Cu-labeled daratumumab F(ab')2 fragment enables early visualization of CD38-positive lymphoma, 2021, European Journal of Nuclear Medicine and Molecular Imaging

The scientist frequently collaborates with others, including Lei Kang, Chunli Zhang, Cuicui Li, Zhao Chen, and Xuhe Liao.

Best Publications

  • Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli.

    Rong Fu Wang;Sidney R. Kushner

  • Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity

    Unknown

  • Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function.

    Gyangyong Peng;Zhong Guo;Yukiko Kiniwa;Kui Shin Voo

  • Tumor-Specific Human CD4+ Regulatory T Cells and Their Ligands: Implications for Immunotherapy

    Helen Yicheng Wang;Dean A. Lee;Guangyong Peng;Zhong Guo

  • Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis.

    Qianquan Ma;Qianquan Ma;Changsheng Xing;Wenyong Long;Helen Yicheng Wang

  • Cancer therapy using a self-replicating RNA vaccine

    Han Ying;Tal Z. Zaks;Rong Fu Wang;Kari R. Irvine

  • NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways

    Jun Cui;Liang Zhu;Liang Zhu;Xiaojun Xia;Helen Y. Wang

  • Tumor-Infiltrating γδ T Cells Suppress T and Dendritic Cell Function via Mechanisms Controlled by a Unique Toll-like Receptor Signaling Pathway

    Guangyong Peng;Helen Yicheng Wang;Helen Yicheng Wang;Weiyi Peng;Weiyi Peng;Yukiko Kiniwa

  • Regulatory T cells and cancer

    Helen Yicheng Wang;Rongfu Wang

  • Cloning Genes Encoding MHC Class II-Restricted Antigens: Mutated CDC27 as a Tumor Antigen

    Rong Fu Wang;Xiang Wang;Alicia C. Atwood;Suzanne L. Topalian

  • Cell type-specific function of TAK1 in innate immune signaling.

    Adebusola A. Ajibade;Helen Yicheng Wang;Rongfu Wang

  • CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer

    Yukiko Kiniwa;Yoshihiro Miyahara;Helen Yicheng Wang;Weiyi Peng

  • Human tumor antigens for cancer vaccine development.

    Rong Fu Wang;Steven A. Rosenberg

  • Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation.

    Tuo Deng;Christopher J. Lyon;Laurie J. Minze;Jianxin Lin

  • Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

    Rong Fu Wang;Steven A. Rosenberg

  • Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes.

    Rong-Fu Wang;P. F. Robbins;Y. Kawakami;Xiao-Qiang Kang

  • Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer

    Yoshihiro Miyahara;Kunle Odunsi;Wenhao Chen;Guangyong Peng

  • Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen.

    Rong Fu Wang;Maria R. Parkhurst;Yutaka Kawakami;Paul F. Robbins

  • The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity

    Rong-Fu Wang

  • NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4

    Jun Cui;Yinyin Li;Yinyin Li;Yinyin Li;Liang Zhu;Dan Liu

  • TRIM14 Inhibits cGAS Degradation Mediated by Selective Autophagy Receptor p62 to Promote Innate Immune Responses.

    Meixin Chen;Qingcai Meng;Yunfei Qin;Puping Liang

Frequent Co-Authors

Steven A. Rosenberg
Steven A. Rosenberg National Institutes of Health
Paul F. Robbins
Paul F. Robbins National Cancer Institute
Xin-zhuan Su
Xin-zhuan Su National Institutes of Health
Yutaka Kawakami
Yutaka Kawakami International University Of Health And Welfare Atami Hospital
Guangyong Peng
Guangyong Peng Saint Louis University
Jian Wu
Jian Wu Fudan University
Haifa Shen
Haifa Shen Houston Methodist
Mauro Ferrari
Mauro Ferrari Houston Methodist
Nicholas P. Restifo
Nicholas P. Restifo National Institutes of Health
Carole A. Long
Carole A. Long National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, complementary online degrees can broaden career opportunities in healthcare and research. Nursing is a popular pathway, with various specializations aligning well with immunological knowledge. Exploring the cheapest pmhnp programs online can be an excellent start for students seeking affordable Psychiatric-Mental Health Nurse Practitioner degrees, which often complement immunology in understanding neurological-immune interactions.

Advancing clinical nursing careers frequently involves earning a Doctor of Nursing Practice (DNP). It's important to understand how much a DNP can make to weigh the investment. Detailed insights on how much does a dnp make offer valuable information for those considering this advanced degree.

Transitioning within nursing specialties is also common. For instance, nurses moving from primary care to more specialized roles should review acute care nurse practitioner programs. These programs focus on patients with complex conditions, a setting where immunology expertise can be highly advantageous.

Additionally, accelerated options like accelerated rn to np programs enable registered nurses to fast-track their nurse practitioner credentials, opening doors to advanced practice roles sooner. This flexibility benefits those aiming to integrate immunology knowledge with clinical practice in dynamic healthcare environments.

Best Scientists Citing Rongfu Wang

Trending Scientists

Recently Published Articles